1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antiparasitic
1.2.3 Anti-infectives
1.2.4 NSAIDs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Companion Animals
1.3.3 Production/Food Animals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Perspective (2018-2029)
2.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Growth Trends by Region
2.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size by Region (2018-2023)
2.2.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Region (2024-2029)
2.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
2.3.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Trends
2.3.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Drivers
2.3.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Challenges
2.3.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Active Pharmaceutical Ingredients Manufacturing Players by Revenue
3.1.1 Global Top Veterinary Active Pharmaceutical Ingredients Manufacturing Players by Revenue (2018-2023)
3.1.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Players (2018-2023)
3.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue
3.4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Concentration Ratio
3.4.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue in 2022
3.5 Veterinary Active Pharmaceutical Ingredients Manufacturing Key Players Head office and Area Served
3.6 Key Players Veterinary Active Pharmaceutical Ingredients Manufacturing Product Solution and Service
3.7 Date of Enter into Veterinary Active Pharmaceutical Ingredients Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Active Pharmaceutical Ingredients Manufacturing Breakdown Data by Type
4.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size by Type (2018-2023)
4.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Type (2024-2029)
5 Veterinary Active Pharmaceutical Ingredients Manufacturing Breakdown Data by Application
5.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size by Application (2018-2023)
5.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size (2018-2029)
6.2 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2018-2023)
6.4 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size (2018-2029)
7.2 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2018-2023)
7.4 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size (2018-2029)
8.2 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (2018-2023)
8.4 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size (2018-2029)
9.2 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2018-2023)
9.4 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size (2018-2029)
10.2 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2018-2023)
10.4 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alivira Animal Health Ltd.
11.1.1 Alivira Animal Health Ltd. Company Detail
11.1.2 Alivira Animal Health Ltd. Business Overview
11.1.3 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.1.4 Alivira Animal Health Ltd. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.1.5 Alivira Animal Health Ltd. Recent Development
11.2 Chempro Pharma Private Ltd.
11.2.1 Chempro Pharma Private Ltd. Company Detail
11.2.2 Chempro Pharma Private Ltd. Business Overview
11.2.3 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.2.4 Chempro Pharma Private Ltd. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.2.5 Chempro Pharma Private Ltd. Recent Development
11.3 Excel Industries Ltd.
11.3.1 Excel Industries Ltd. Company Detail
11.3.2 Excel Industries Ltd. Business Overview
11.3.3 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.3.4 Excel Industries Ltd. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.3.5 Excel Industries Ltd. Recent Development
11.4 FIS - Fabbrica Italiana Sintetici S.p.A.
11.4.1 FIS - Fabbrica Italiana Sintetici S.p.A. Company Detail
11.4.2 FIS - Fabbrica Italiana Sintetici S.p.A. Business Overview
11.4.3 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.4.4 FIS - Fabbrica Italiana Sintetici S.p.A. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.4.5 FIS - Fabbrica Italiana Sintetici S.p.A. Recent Development
11.5 HIKAL Ltd.
11.5.1 HIKAL Ltd. Company Detail
11.5.2 HIKAL Ltd. Business Overview
11.5.3 HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.5.4 HIKAL Ltd. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.5.5 HIKAL Ltd. Recent Development
11.6 HuBei Masteam Bio-tech
11.6.1 HuBei Masteam Bio-tech Company Detail
11.6.2 HuBei Masteam Bio-tech Business Overview
11.6.3 HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.6.4 HuBei Masteam Bio-tech Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.6.5 HuBei Masteam Bio-tech Recent Development
11.7 Hunan Huateng Pharmaceutical
11.7.1 Hunan Huateng Pharmaceutical Company Detail
11.7.2 Hunan Huateng Pharmaceutical Business Overview
11.7.3 Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.7.4 Hunan Huateng Pharmaceutical Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.7.5 Hunan Huateng Pharmaceutical Recent Development
11.8 Jiangsu Rivocean
11.8.1 Jiangsu Rivocean Company Detail
11.8.2 Jiangsu Rivocean Business Overview
11.8.3 Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.8.4 Jiangsu Rivocean Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.8.5 Jiangsu Rivocean Recent Development
11.9 Ofichem Group
11.9.1 Ofichem Group Company Detail
11.9.2 Ofichem Group Business Overview
11.9.3 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.9.4 Ofichem Group Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.9.5 Ofichem Group Recent Development
11.10 Qilu Pharma Spain, S.A.
11.10.1 Qilu Pharma Spain, S.A. Company Detail
11.10.2 Qilu Pharma Spain, S.A. Business Overview
11.10.3 Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.10.4 Qilu Pharma Spain, S.A. Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.10.5 Qilu Pharma Spain, S.A. Recent Development
11.11 Menadiona
11.11.1 Menadiona Company Detail
11.11.2 Menadiona Business Overview
11.11.3 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.11.4 Menadiona Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.11.5 Menadiona Recent Development
11.12 Nissan Chemical
11.12.1 Nissan Chemical Company Detail
11.12.2 Nissan Chemical Business Overview
11.12.3 Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.12.4 Nissan Chemical Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.12.5 Nissan Chemical Recent Development
11.13 SUANFARMA
11.13.1 SUANFARMA Company Detail
11.13.2 SUANFARMA Business Overview
11.13.3 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.13.4 SUANFARMA Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.13.5 SUANFARMA Recent Development
11.14 Siflon Drugs
11.14.1 Siflon Drugs Company Detail
11.14.2 Siflon Drugs Business Overview
11.14.3 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.14.4 Siflon Drugs Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.14.5 Siflon Drugs Recent Development
11.15 Shaanxi Dideu Group
11.15.1 Shaanxi Dideu Group Company Detail
11.15.2 Shaanxi Dideu Group Business Overview
11.15.3 Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.15.4 Shaanxi Dideu Group Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.15.5 Shaanxi Dideu Group Recent Development
11.16 Taizhou Crene Biotechnology
11.16.1 Taizhou Crene Biotechnology Company Detail
11.16.2 Taizhou Crene Biotechnology Business Overview
11.16.3 Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.16.4 Taizhou Crene Biotechnology Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.16.5 Taizhou Crene Biotechnology Recent Development
11.17 Zhejiang Gihi Chemicals
11.17.1 Zhejiang Gihi Chemicals Company Detail
11.17.2 Zhejiang Gihi Chemicals Business Overview
11.17.3 Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.17.4 Zhejiang Gihi Chemicals Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.17.5 Zhejiang Gihi Chemicals Recent Development
11.18 Vetpharma (Insud Pharma, S.L.U)
11.18.1 Vetpharma (Insud Pharma, S.L.U) Company Detail
11.18.2 Vetpharma (Insud Pharma, S.L.U) Business Overview
11.18.3 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Introduction
11.18.4 Vetpharma (Insud Pharma, S.L.U) Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing Business (2018-2023)
11.18.5 Vetpharma (Insud Pharma, S.L.U) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
